Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

33
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
33
Pericarditis II: Clinical Features and Diagnostic Tests01:19

Pericarditis II: Clinical Features and Diagnostic Tests

36
Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...
36
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

22
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
22
Pericarditis I: Introduction01:22

Pericarditis I: Introduction

27
Pericarditis is defined as the inflammation of the pericardium, the thin, sac-like membrane surrounding the heart. This condition can cause significant chest pain and other symptoms, often necessitating medical intervention. The pericardium has two layers: the inner visceral layer and the outer parietal layer, separated by a small amount of fluid that reduces friction during heartbeats.Types of PericarditisPericarditis can be classified into several types based on the duration and nature of the...
27
Pericarditis IV: Nursing Management01:25

Pericarditis IV: Nursing Management

64
Pericarditis, an inflammation of the pericardium, necessitates diligent nursing management to ensure effective patient care and recovery. The initial step in managing pericarditis is a comprehensive patient medical assessment.The patient reports chest pain aggravated by breathing, coughing, and swallowing, which worsens when lying supine. The pain often improves when sitting up and leaning forward. Additional symptoms may include fever, malaise, and, in severe cases, signs of heart failure.
64
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

36
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
36

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Novel risk model for predicting incident atrial fibrillation in patients taking ω-3 fatty acid: sub-analysis of the STRENGTH randomized trial.

American journal of preventive cardiology·2026
Same author

Expert Opinion: Restrictions, Precautions, or Normalcy? Defining Everyday Risk in Patients Treated With IL-1 Blockers for Recurrent Pericarditis.

Journal of cardiovascular pharmacology·2026
Same author

Hydroxychloroquine for recurrent pericarditis: Old drug, new role.

European journal of internal medicine·2026
Same author

Navigating the Spectrum of Inflammatory Myocardial and Pericardial Syndromes: A Contemporary Approach to Diagnosis and Management.

Journal of cardiac failure·2026
Same author

Contemporary characteristics and outcomes of valve surgery for carcinoid heart disease.

JTCVS open·2026
Same author

Perioperative Continuation of Interleukin-1 Blockade in Chronic Constrictive Pericarditis: Imaging-Guided Surgical Decision.

JACC. Case reports·2026

Related Experiment Video

Updated: Sep 20, 2025

Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model
14:24

Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model

Published on: January 21, 2018

11.8K

Recent advances in multimodality imaging-guided therapy in pericarditis.

Joseph El Roumi1, Aldo L Schenone2, Paul Cremer3

  • 1Center for the Diagnosis and Treatment of Pericardial Diseases, Section of Cardiovascular Imaging, Robert and Suzanne Tomsich Department of Cardiovascular Medicine, Sydell and Arnold Miller Family Heart, Vascular, and Thoracic Institute, Cleveland Clinic, Cleveland, Ohio, USA.

European Journal of Clinical Investigation
|May 23, 2025
PubMed
Summary

Cardiac multimodality imaging, including echocardiography, CMR, CT, and PET, is crucial for diagnosing and managing pericarditis. Integrating imaging with clinical data guides personalized, inflammation-targeted therapies for better patient outcomes.

Keywords:
cardiac CTcardiac magnetic resonanceechocardiographymultimodality imagingpericardial constrictionpericarditis

More Related Videos

MRI and PET in Mouse Models of Myocardial Infarction
10:46

MRI and PET in Mouse Models of Myocardial Infarction

Published on: December 19, 2013

11.9K
Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System
10:17

Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System

Published on: April 11, 2025

969

Related Experiment Videos

Last Updated: Sep 20, 2025

Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model
14:24

Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model

Published on: January 21, 2018

11.8K
MRI and PET in Mouse Models of Myocardial Infarction
10:46

MRI and PET in Mouse Models of Myocardial Infarction

Published on: December 19, 2013

11.9K
Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System
10:17

Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System

Published on: April 11, 2025

969

Area of Science:

  • Cardiology
  • Medical Imaging
  • Inflammatory Diseases

Background:

  • Pericarditis diagnosis and management rely on precise imaging techniques in precision medicine.
  • Inflammation and recurrent episodes characterize pericarditis, necessitating advanced diagnostic tools.

Purpose of the Study:

  • To review the role of cardiac multimodality imaging in pericarditis.
  • To highlight the value of imaging-guided therapy for pericarditis management.

Main Methods:

  • Systematic review of high-quality medical literature.
  • Focus on multimodality imaging techniques and imaging-guided therapy in pericarditis.

Main Results:

  • Echocardiography detects effusion and hemodynamics; advanced imaging (CMR, CT, PET) visualizes inflammation, calcifications, and metabolic activity.
  • Cardiac magnetic resonance imaging (CMR) excels at visualizing pericardial inflammation via late gadolinium enhancement.
  • Cardiac computed tomography (CT) detects calcifications and thickening; positron emission tomography (PET) quantifies inflammation.
  • Imaging biomarkers are key for confirming inflammation, assessing treatment response, and monitoring complications.

Conclusions:

  • Integrating imaging findings with clinical and biomarker data aids tailored therapy and patient stratification.
  • Imaging-guided therapy is valuable for managing pericarditis, potentially identifying candidates for IL-1 blockade.